Jha, B. S., Farnoodian, M., & Bharti, K. (2020). Regulatory considerations for developing a phase I investigational new drug application for autologous induced pluripotent stem cells‐based therapy product. Stem Cells Transl Med.
Citação norma ChicagoJha, Balendu Shekhar, Mitra Farnoodian, and Kapil Bharti. "Regulatory Considerations for Developing a Phase I Investigational New Drug Application for Autologous Induced Pluripotent Stem Cells‐based Therapy Product." Stem Cells Transl Med 2020.
Citação norma MLAJha, Balendu Shekhar, Mitra Farnoodian, and Kapil Bharti. "Regulatory Considerations for Developing a Phase I Investigational New Drug Application for Autologous Induced Pluripotent Stem Cells‐based Therapy Product." Stem Cells Transl Med 2020.